Posted on July 29th, 2010 by Health News
One of the most comprehensive reports comparing the use of medicines in the UK with that in other countries has been published by the Department of Health. The report shows that the UK still lags behind comparable countries in Europe and elsewhere on its use of newer cancer treatments and medicines for chronic diseases such as rheumatoid arthritis, multiple sclerosis and dementia…
Read more
Filed under: Pharmacy News
Tags: Arthritis, cancer, Chronic Disease, medicine, Pharmacy, sclerosis
Related posts
- VisEn Medical launches two new agents for imaging quantification (0)
VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced today the commercial launch of its new OsteoSense® 800 imaging agent for targeting areas of bone turnover and microcalcification in vivo. The new 800 nm OsteoSense agent complements VisEn's OsteoSense 680 and 750 products, and is expected to further expand [...]
- Anti-malaria drug provides key insight into potential treatments for autoimmune diseases (0)
In a study published recently in the journal Science Signaling Van Andel Research Institute (VARI) scientists demonstrate on the molecular level how the anti-malaria drug chloroquine represses inflammation, which may provide a blueprint for new strategies for treating inflammation and a multitude of autoimmune diseases such as arthritis, multiple sclerosis, and certain cancers.
Read more
[tags] Pharmacy [...]
- Æterna Zentaris Zentaris requests EMA Scientific Advice for Phase 3 program with perifosine (0)
Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that it has requested Scientific Advice from the European Medicines Agency (EMA) to assure the acceptability of the recently initiated Phase 3 programs for the development of its lead anticancer compound, perifosine, in its two lead indications, multiple myeloma [...]
- When To Administer Food And Drugs Together (0)
A regulatory bias against taking oral anti-cancer medications with food places many patients at increased risk for an overdose and forces them to "flush costly medicines down the toilet," argues Mark Ratain, MD, an authority on cancer-drug dosing. In a commentary published early online Sept. 19 in the Journal of Clinical Oncology, Ratain, the Leon [...]
- What Is Herceptin (trastuzumab)? What Is Herceptin For? (0)
Herceptin is the brand name of a medicine called trastuzumab. This medicine can stop the growth of breast cancer and sometimes reduce the size of the tumor. Herceptin is given by a drip into a vein. It can be given in combination with chemotherapy, or on its own to patients who have already had [...]
Leave a Reply